Key Stats

Expense Ratio Total Assets Under Management Dividend Yield Turnover Ratio
2.06% 1.006B 0.96% 25.00%
1 Year Fund Level Flows 1 Year Total Returns (Daily) Annualized All Time Total Returns (Daily) Max Drawdown (All)
-7.563M -7.89% Upgrade Upgrade

Basic Info

Investment Strategy
The investment seeks current income and capital appreciation. The fund generally invests in a diversified portfolio consisting of equity securities of U.S. companies that have a history of attractive dividend yields and positive growth in operating cash flow. It invests at least 80% of its assets (net assets plus any borrowings for investment purposes) in equity securities of dividend-paying U.S. companies across all market capitalizations. The fund may invest up to 15% of its net assets in foreign securities.
General
Security Type Mutual Fund
Oldest Share Symbol EPLCX
Equity Style Large Cap/Value
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Large Value
Category Index Russell 1000 Value TR USD
Global Category Name US Equity Large Cap Value
YCharts Categorization US Large Cap Value
YCharts Benchmark Russell 1000 Value Total Return (^RLVTR)
Prospectus Objective Growth and Income
Fund Owner Firm Name New York Life Investment Management LLC
Prospectus Benchmark Index
Russell 1000 Value TR USD 100.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Michael Welhoelter 13.84 yrs
William Priest 13.84 yrs
John Tobin 10.01 yrs
Kera Van Valen 10.01 yrs

Net Fund Flows Versus Category

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: 42
-7.563M
-6.415B Category Low
13.81B Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
As of February 28, 2023

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of March 24, 2023. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
13.52%
15.62%
-6.50%
22.52%
-1.12%
21.30%
-3.83%
-5.05%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
3.86%
9.60%
18.71%
-8.38%
24.55%
7.42%
25.11%
-7.84%
-1.74%
12.99%
15.57%
-9.28%
22.10%
0.59%
25.05%
-5.11%
-3.49%
8.54%
17.17%
-11.14%
12.86%
--
--
--
--
12.71%
17.81%
-9.00%
28.92%
5.04%
25.89%
-3.80%
-2.28%
As of March 24, 2023.

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (3-24-23) 0.96%
30-Day SEC Yield (1-31-23) Upgrade
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 17.54
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of February 28, 2023

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of February 28, 2023

Asset Allocation

As of February 28, 2023.
Type % Net % Long % Short
Cash 1.41% Upgrade Upgrade
Stock 98.36% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.23% Upgrade Upgrade

Top 10 Holdings

Name % Weight Price % Change
JPMorgan Chase & Co 2.18% 124.91 -1.52%
Broadcom Inc 2.17% 636.17 -0.48%
AbbVie Inc 2.15% 158.02 1.75%
MetLife Inc 2.11% 54.35 0.09%
Chevron Corp 2.01% 156.06 1.00%
U.S. Bancorp 1.97% 34.90 -0.46%
Analog Devices Inc 1.91% 187.69 -0.93%
UnitedHealth Group Inc 1.90% 475.99 1.29%
Merck & Co Inc 1.87% 104.80 0.55%
Medtronic PLC 1.74% 79.37 2.32%

Fees & Availability

Fees
Actual 12B-1 Fee Upgrade
Actual Management Fee Upgrade
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load Upgrade
Maximum Redemption Fee --
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment Upgrade
Minimum Subsequent Investment Upgrade

Basic Info

Investment Strategy
The investment seeks current income and capital appreciation. The fund generally invests in a diversified portfolio consisting of equity securities of U.S. companies that have a history of attractive dividend yields and positive growth in operating cash flow. It invests at least 80% of its assets (net assets plus any borrowings for investment purposes) in equity securities of dividend-paying U.S. companies across all market capitalizations. The fund may invest up to 15% of its net assets in foreign securities.
General
Security Type Mutual Fund
Oldest Share Symbol EPLCX
Equity Style Large Cap/Value
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Large Value
Category Index Russell 1000 Value TR USD
Global Category Name US Equity Large Cap Value
YCharts Categorization US Large Cap Value
YCharts Benchmark Russell 1000 Value Total Return (^RLVTR)
Prospectus Objective Growth and Income
Fund Owner Firm Name New York Life Investment Management LLC
Prospectus Benchmark Index
Russell 1000 Value TR USD 100.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Michael Welhoelter 13.84 yrs
William Priest 13.84 yrs
John Tobin 10.01 yrs
Kera Van Valen 10.01 yrs

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (3-24-23) 0.96%
30-Day SEC Yield (1-31-23) Upgrade
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 17.54
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of February 28, 2023

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of February 28, 2023

Fund Details

Key Dates
Inception Date 5/8/2017
Last Annual Report Date 10/31/2022
Last Prospectus Date 2/28/2023
Share Classes
EPLCX Inst
EPLDX Retirement
EPLIX Inv
EPLKX C
EPLMX Other
EPLPX A
EPLRX Retirement
EPLSX Retirement
EPLTX Retirement
Attributes
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No

Top Portfolio Holders

0 of 0